> Detailanzeige

Zhao, Kai; Braun, Madita; Meyer, Leonie; Otte, Katharina; Raifer, Hartmann; Helmprobst, Frederik; Möschl, Vincent; Pagenstecher, Axel; Urban, Hans; Ronellenfitsch, Michael W.; Steinbach, Joachim P.; Pesek, Jelena; Watzer, Bernhard; Nockher, Wolfgang A.; Taudte, R. Verena; Neubauer, Andreas; Nimsky, Christopher; Bartsch, Jörg W.; Rusch, Tillmann

A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
  • Beteiligte: Zhao, Kai; Braun, Madita; Meyer, Leonie; Otte, Katharina; Raifer, Hartmann; Helmprobst, Frederik; Möschl, Vincent; Pagenstecher, Axel; Urban, Hans; Ronellenfitsch, Michael W.; Steinbach, Joachim P.; Pesek, Jelena; Watzer, Bernhard; Nockher, Wolfgang A.; Taudte, R. Verena; Neubauer, Andreas; Nimsky, Christopher; Bartsch, Jörg W.; Rusch, Tillmann
  • Erschienen: MDPI AG, 2024
  • Erschienen in: Cells, 13 (2024) 7, Seite 632
  • Sprache: Englisch
  • DOI: 10.3390/cells13070632
  • ISSN: 2073-4409
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Adjuvant treatment for Glioblastoma Grade 4 with Temozolomide (TMZ) inevitably fails due to therapeutic resistance, necessitating new approaches. Apoptosis induction in GB cells is inefficient, due to an excess of anti-apoptotic XPO1/Bcl-2-family proteins. We assessed TMZ, Methotrexate (MTX), and Cytarabine (Ara-C) (apoptosis inducers) combined with XPO1/Bcl-2/Mcl-1-inhibitors (apoptosis rescue) in GB cell lines and primary GB stem-like cells (GSCs). Using CellTiter-Glo® and Caspase-3 activity assays, we generated dose–response curves and analyzed the gene and protein regulation of anti-apoptotic proteins via PCR and Western blots. Optimal drug combinations were examined for their impact on the cell cycle and apoptosis induction via FACS analysis, paralleled by the assessment of potential toxicity in healthy mouse brain slices. Ara-C and MTX proved to be 150- to 10,000-fold more potent in inducing apoptosis than TMZ. In response to inhibitors Eltanexor (XPO1; E), Venetoclax (Bcl-2; V), and A1210477 (Mcl-1; A), genes encoding for the corresponding proteins were upregulated in a compensatory manner. TMZ, MTX, and Ara-C combined with E, V, and A evidenced highly lethal effects when combined. As no significant cell death induction in mouse brain slices was observed, we conclude that this drug combination is effective in vitro and expected to have low side effects in vivo.
  • Zugangsstatus: Freier Zugang